MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cartron, P.-F.
Right arrow Articles by Vallette, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cartron, P.-F.
Right arrow Articles by Vallette, F. M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, July 2003, p. 4701-4712, Vol. 23, No. 13
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.13.4701-4712.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Nonredundant Role of Bax and Bak in Bid-Mediated Apoptosis

Pierre-François Cartron,1 Philippe Juin,1 Lisa Oliver,1 Stéphane Martin,1,2 Khaled Meflah,1 and François M. Vallette1*

INSERM U419, IFR 26, 44035 Nantes Cedex 01,1 Clinique Universitaire de Neurochirurgie, Hôpital G & R Laennec, CHU Nantes, 44093 Nantes Cedex 01, France2

Received 21 November 2002/ Returned for modification 17 January 2003/ Accepted 17 March 2003

Animal models suggest that Bax and Bak play an essential role in the implementation of apoptosis and as a result can hinder tumorigenesis. We analyzed the expression of these proteins in 50 human glioblastoma multiforme (GBM) tumors. We found that all the tumors expressed Bak, while three did not express Bax. In vitro, Bax-deficient GBM (BdGBM) exhibited an important resistance to various apoptogenic stimuli (e.g., UV, staurosporine, and doxorubicin) compared to the Bax-expressing GBM (BeGBM). Using an antisense strategy, we generated Bak- BeGBM and Bak- BdGBM, which enabled us to show that the remaining sensitivity of the BdGBM to apoptosis was due to the overexpression of Bak. Bax/Bak single or double deficiency had no influence on either the clonogenicity or the growth of tumors in Swiss nude mice. Of note, Bak- BeGBM cells were resistant to apoptosis induced by caspase 8 (C8) but not to that induced by granzyme B (GrB). Cells lacking both Bax and Bak (i.e., Bak- BdGBM) were completely resistant to all stimuli including the microinjection of C8 and GrB. We show that GrB-cleaved Bid and C8-cleaved Bid differ in size and utilize preferentially Bax and Bak, respectively, to promote cytochrome c release from mitochondria. Our results suggest that Bax deficiency is compensated by an increase of the expression of Bak in GBM and show, for the first time in human cancer, that the double Bax and Bak deficiency severely impairs the apoptotic program.


* Corresponding author. Mailing address: INSERM U 419, IFR 26, 9 Quai Moncousu, 44035 Nantes Cedex 01, France. Phone: 33/0-240084081. Fax 33/0-240084082. E-mail: fval{at}nantes.inserm.fr.


Molecular and Cellular Biology, July 2003, p. 4701-4712, Vol. 23, No. 13
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.13.4701-4712.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2003 by the American Society for Microbiology. All rights reserved.